GeoVax Labs Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-24.99	-25.97	-14.02	-18.57	-2.96	Upgrade
Depreciation & Amortization	0.1	0.07	0.06	0.04	0.02	Upgrade
Other Amortization	-	-	-	-	0.12	Upgrade
Stock-Based Compensation	0.53	1.07	0.9	0.37	0.06	Upgrade
Other Operating Activities	-	-	-	0.04	-	Upgrade
Change in Accounts Receivable	-0.66	-	0.05	0.13	-0.11	Upgrade
Change in Accounts Payable	-0.41	-1.23	-2.69	6.81	0.14	Upgrade
Change in Other Net Operating Assets	0.76	0.87	-3.33	-0.02	-0.02	Upgrade
Operating Cash Flow	-24.68	-25.17	-19.03	-11.2	-2.75	Upgrade
Capital Expenditures	-0.02	-0.05	-0.13	-0.05	-0.16	Upgrade
Investing Cash Flow	-0.02	-0.05	-0.13	-0.05	-0.16	Upgrade
Short-Term Debt Issued	0.14	-	-	-	0.89	Upgrade
Long-Term Debt Issued	-	-	-	-	0.17	Upgrade
Total Debt Issued	0.14	-	-	-	1.06	Upgrade
Short-Term Debt Repaid	-0.15	-	-	-	-	Upgrade
Long-Term Debt Repaid	-	-	-	-0.03	-0.01	Upgrade
Total Debt Repaid	-0.15	-	-	-0.03	-0.01	Upgrade
Net Debt Issued (Repaid)	-0.02	-	-	-0.03	1.05	Upgrade
Issuance of Common Stock	23.77	4.06	35.35	12.81	11.16	Upgrade
Financing Cash Flow	23.75	4.06	35.35	12.78	12.51	Upgrade
Net Cash Flow	-0.95	-21.16	16.19	1.54	9.6	Upgrade
Free Cash Flow	-24.7	-25.22	-19.16	-11.24	-2.91	Upgrade
Free Cash Flow Margin	-624.50%	-	-23507.18%	-2916.76%	-159.42%	Upgrade
Free Cash Flow Per Share	-4.76	-13.88	-16.94	-27.65	-31.51	Upgrade
Levered Free Cash Flow	-16.53	-16.95	-9.75	-6.4	-3.36	Upgrade
Unlevered Free Cash Flow	-16.52	-16.95	-9.75	-6.4	-3.4	Upgrade
Change in Net Working Capital	1.41	1.34	1.81	-4.95	1.56	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q